Soluble endothelial selectin in acute lung injury complicated by severe pneumonia

International Journal of Medical Sciences

Volumn 8, Issue 4, 2011, Pages 302-308

  Osaka, Daisuke ^a   Shibata, Yoko ^a   Kanouchi, Kazunori ^b   Nishiwaki, Michiko ^a   Kimura, Tomomi ^a   Kishi, Hiroyuki ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Tokairin, Yoshikane ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Aida, Yasuko ^a   Nemoto, Takako ^a   Nunomiya, Keiko ^a   Fukuzaki, Koji ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute lung injury; Pneumonia; Soluble endothelial selectin

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; SELECTIN; SOLUBLE ENDOTHELIAL SELECTIN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL;

EID: 79958803135     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.302     Document Type: Article

References (31)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet. 1997; 349: 1269-76.
2. Ware LB, Matthay MA. The acute respiratory distress syn-drome. N Engl J Med. 2000; 342: 1334-49.
3. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: Summary of a national heart, lung, and blood institute working group. Am J Respir Crit Care Med. 2003; 167: 1027-35.
4. Balamayooran G, Batra S, Fessler MB, et al. Mechanisms of neutrophil accumulation in the lungs against bacteria. Am J Respir Cell Mol Biol. 2010; 43: 5-16.
5. Endo S, Shibata S, Sato N, et al. A prospective cohort study of ali/ards in the tohoku district of japan (second report). J Anesth. 2010; 24: 351-8.
6. Mortelliti MP, Manning HL. Acute respiratory distress syn-drome. Am Fam Physician. 2002; 65: 1823-30.
7. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994; 8: 504-12.
8. Korkmaz S, Ileri M, Hisar I, et al. Increased levels of soluble adhesion molecules, e-selectin and p-selectin, in patients with infective endocarditis and embolic events. Eur Heart J. 2001; 22: 874-8.
9. Roldan V, Marin F, Lip GY, et al. Soluble e-selectin in cardio-vascular disease and its risk factors. A review of the literature. Thromb Haemost. 2003; 90: 1007-20.
10. Darveau RP, Cunningham MD, Bailey T, et al. Ability of bacte-ria associated with chronic inflammatory disease to stimulate e-selectin expression and promote neutrophil adhesion. Infect Immun. 1995; 63: 1311-7.
11. Benekli M, Gullu IH, Tekuzman G, et al. Circulating intercel-lular adhesion molecule-1 and e-selectin levels in gastric cancer. Br J Cancer. 1998; 78: 267-71.
12. McMurray RW. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum. 1996; 25: 215-33.
13. Gearing AJ, Hemingway I, Pigott R, et al. Soluble forms of vascular adhesion molecules, e-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann N Y Acad Sci. 1992; 667: 324-31.
14. Kayal S, Jais JP, Aguini N, et al. Elevated circulating e-selectin, intercellular adhesion molecule 1, and von willebrand factor in patients with severe infection. Am J Respir Crit Care Med. 1998; 157: 776-84.
15. Newman W, Beall LD, Carson CW, et al. Soluble e-selectin is found in supernatants of activated endothelial cells and is ele-vated in the serum of patients with septic shock. J Immunol. 1993; 150: 644-54.
16. Reinhart K, Bayer O, Brunkhorst F, et al. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 2002; 30: S302-12.
17. Okajima K, Harada N, Sakurai G, et al. Rapid assay for plasma soluble e-selectin predicts the development of acute respiratory distress syndrome in patients with systemic inflammatory re-sponse syndrome. Transl Res. 2006; 148: 295-300.
18. Shindo Y, Sato S, Maruyama E, et al. Comparison of severity scoring systems A-DROP and CURB-65 for communi-ty-acquired pneumonia. Respirology. 2008; 13: 731-5.
19. Wheeler AP, Bernard GR. Acute lung injury and the acute res-piratory distress syndrome: A clinical review. Lancet. 2007; 369: 1553-64.
20. Rice TW, Wheeler AP, Bernard GR, et al. Comparison of the SpO2/FiO2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or ARDS. Chest. 2007; 132: 410-7.
21. Kallstrom TJ. Aarc clinical practice guideline: Oxygen therapy for adults in the acute care facility--2002 revision & update. Respir Care. 2002; 47: 717-20.
22. Kawabata K, Suzuki M, Sugitani M, et al. Ono-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 1991; 177: 814-20.
23. Albelda SM. Endothelial and epithelial cell adhesion molecules. Am J Respir Cell Mol Biol. 1991; 4: 195-203.
24. Standiford TJ, Kunkel SL, Greenberger MJ, et al. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol. 1996; 59: 24-8.
25. Maus U, Rosseau S, Knies U, et al. Expression of pro-inflammatory cytokines by flow-sorted alveolar macro-phages in severe pneumonia. Eur Respir J. 1998; 11: 534-41.
26. Glynn P, Coakley R, Kilgallen I, et al. Neutrophil CD11b and soluble ICAM-1 and e-selectin in community acquired pneu-monia. Eur Respir J. 1999; 13: 1380-5.
27. Okayama N, Kakihana Y, Setoguchi D, et al. Clinical effects of a neutrophil elastase inhibitor, sivelestat, in patients with acute respiratory distress syndrome. J Anesth. 2006; 20: 6-10.
28. Abe S, Nakamura H, Inoue S, et al. Interleukin-8 gene repres-sion by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2000; 22: 51-60.
29. Nakamura H, Yoshimura K, Jaffe HA, et al. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem. 1991; 266: 19611-7.
30. Shibata Y, Nakamura H, Kato S, et al. Cellular detachment and deformation induce IL-8 gene expression in human bronchial epithelial cells. J Immunol. 1996; 156: 772-7.
31. Misumi T, Tanaka T, Mikawa K, et al. Effects of sivelestat, a new elastase inhibitor, on IL-8 and MCP-1 production from stimulated human alveolar epithelial type II cells. J Anesth. 2006; 20: 159-65.